Related Experiment Video
Updated: Dec 3, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Erythropoietin Resistance in Patients with Chronic Kidney Disease: Current Perspectives
Elton Jonh Freitas Santos1, Raimunda Sheyla Carneiro Dias1, Janielle Ferreira de Brito Lima1
1University Hospital of the Federal University of Maranhão, São Luís, Brazil.
Abstract:
Anemia is a frequent complication of chronic kidney disease, and its primary cause is erythropoietin deficiency. After diagnosis, treatment begins with administration of an erythropoiesis-stimulating agent (ESA). However, some patients present with resistance to ESA, which needs to be reversed, as it can increase the risk of death in patients with kidney disease. Therefore, we provide a discussion of the current literature regarding the factors that can modify the response to this class of drugs and the strategies that can be considered to optimize the benefits of treating anemia.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Heart Failure VI: Adjunct Therapies
Acute Kidney Injury II: Pathophysiology

